Zimmer Biomet Profile

<div class='circular--portrait' style='background:#FF0F00;color: white;font-size:3em;padding-top: 25px;;'>ZBH</div>

Performance

11 / 100

Odds of Distress

Analyze Filter   Earning Report: February 4, 2020
Equity ratings for Zimmer Biomet Holdings are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting October 23, 2019 and ending today January 21, 2020. Click here to learn more.

Zimmer Biomet Profile

Upcoming quarterly earning report is expected on February 4, 2020. Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. Zimmer Biomet operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 19000 people. more on Zimmer Biomet
Legal NameZimmer Biomet Holdings
Thematic Classification
Currently Active Investing Idea
  Obamacare Repeal
View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Zimmer Biomet Holdings.
Piotroski F Score
Academic score to determine the current strength of Zimmer Biomet Holdings financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Financial Strength
Zimmer Biomet Holdings ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Profitability
Few selected profitability drivers of Zimmer Biomet representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
EBITDA Margin
Gross Margin
Profit Margin
Zimmer Biomet Holdings (ZBH) is traded on BATS Exchange in USA and employs 19,000 people. The company currently falls under 'Large-Cap' category with total capitalization of 30.79 B. Zimmer Biomet Holdings runs under Healthcare sector within Medical Devices industry. The entity has 205.68 M outstanding shares of which 1.88 M shares are at this time shorted by investors with about 2.13 days to cover shorted positions. Zimmer Biomet Holdings has about 512.5 M in cash with 1.12 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.49.
Check Zimmer Biomet Probability Of Bankruptcy

Ownership Allocation (%)

Zimmer Biomet Target Price Odds Analysis

Odds Below 149.38HorizonTargetOdds Above 149.38
81.43%30 days 149.38 18.33%
Based on normal probability distribution, the odds of Zimmer Biomet to move above current price in 30 days from now is about 18.33 (This Zimmer Biomet Holdings probability density function shows the probability of Zimmer Biomet Stock to fall within a particular range of prices over 30 days) .

Zimmer Biomet Holdings Top Holders

Zimmer Biomet Holdings Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Zimmer Biomet Against Markets

Did you try this?

Run CEO Directory Now

   

CEO Directory

Screen CEOs from public companies around the world
All  Next Launch Module

Zimmer Biomet Upcoming and Recent Events

Zimmer Biomet Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportFebruary 4, 2020
Next Earnings ReportApril 24, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndFebruary 4, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Zimmer Biomet Corporate Filings

Zimmer Biomet SEC Reporting

Unclassified Corporate Event
Financial Statements and Exhibits. Results of Operations and Financial Condition
Other Events
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Unclassified Corporate Event

Zimmer Biomet Distributions to stockholders

See also Your Current Watchlist. Please also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Company logos by clearbit